Academic Journal
Allogeneic Hematopoietic Stem Cell
العنوان: | Allogeneic Hematopoietic Stem Cell |
---|---|
المؤلفون: | Transplantation In Patients, Rafael De, La Cámara, Arancha Alonso, Juan Luis Steegmann, Reyes Arranz, Enrique Granados, Gabriela Rodríguez-macías, Cesar Sanz-rodríguez, Valle Gómez, De Soria, Angela Figuera |
المساهمون: | The Pennsylvania State University CiteSeerX Archives |
المصدر: | http://www.haematologica.org/full/pdf/2002_09/87965.pdf. |
سنة النشر: | 2002 |
المجموعة: | CiteSeerX |
الوصف: | y different between the elderly and young groups: 51% vs. 55% for all patients; 87% vs. 69% in chronic myeloid leukemia; 79% vs. 62% in standard risk patients and 13% vs. 31% in high risk ones. In multivariate analyses no significant difference in overall survival was found between age groups. Interpretation and Conclusions. According to our experience, age alone (between 50-59), should not be considered a contraindication to a conventional HLA identical sibling transplant. 2002, Ferrata Storti Foundation Key words: allogeneic stem cell transplantation; age; elderly; HLA identical sibling; myeloablative conditioning regimen. T he median age of the patients who receive a stem cell transplantation (SCT) is between 25 and 30 years. 1,2 Nonetheless the majority of patients with hematologic malignancies have a median age well over 50 at diagnosis. Thus, for chronic myeloid leukemia (CML), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), lymphoma and myeloma |
نوع الوثيقة: | text |
وصف الملف: | application/pdf |
اللغة: | English |
Relation: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.7.6929; http://www.haematologica.org/full/pdf/2002_09/87965.pdf |
الاتاحة: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.7.6929 http://www.haematologica.org/full/pdf/2002_09/87965.pdf |
Rights: | Metadata may be used without restrictions as long as the oai identifier remains attached to it. |
رقم الانضمام: | edsbas.27F786E9 |
قاعدة البيانات: | BASE |
الوصف غير متاح. |